Silver Sulfadiazine Nanocrystal-Based Hydrogels: The Impact of Lipid Components on In-vitro and Ex-vivo Release, Bacterial Biofilm Permeability, and In-vitro Antibacterial Activity

Eming SA, Krieg T, Davidson JM. Inflammation in wound repair: molecular and cellular mechanisms. J Invest Dermatology. 2007;127(3):514–25.

Article  CAS  Google Scholar 

Miller AC, Rashid RM, Falzon L, Elamin EM, Zehtabchi S. Silver sulfadiazine for the treatment of partial-thickness burns and venous stasis ulcers. J Am Acad Dermatol. 2012;66(5):e159–65.

Article  CAS  PubMed  Google Scholar 

Hoffmann S. Silver sulfadiazine: an antibacterial agent for topical use in burns. Scand J Plast Reconstr Surg. 1984;18(1):119–26.

CAS  PubMed  Google Scholar 

Ueda Y, Miyazaki M, Mashima K, Takagi S, Hara S, Kamimura H et al. The effects of silver sulfadiazine on methicillin-resistant Staphylococcus aureus biofilms. 2020;8(10):1551.

Kumar PM, Ghosh A. Development and evaluation of silver sulfadiazine loaded microsponge based gel for partial thickness (second degree) burn wounds. Eur J Pharm Sci. 2017;96:243–54.

Article  CAS  PubMed  Google Scholar 

Naser NA, Alasedi KM, Khan ZA. New approach for determination of sulfadiazine in pharmaceutical preparations using 4 (4-sulphophenylazo) pyrogallol: kinetic spectrophotometric method. Spectrochim Acta Part A Mol Biomol Spectrosc. 2018;201:267–80.

Article  CAS  Google Scholar 

Nesbitt RU Jr., Sandmann BJ. Solubility studies of silver sulfadiazine. J Pharm Sci. 1977;66(4):519–22.

Article  CAS  PubMed  Google Scholar 

Pharmacopoeia J. Japanese Pharmacopoeia 17: Official Monographs Sulfadiazine Silve. 2016.

Costerton JW, Stewart PS, Greenberg EPJ. Bacterial biofilms: a common cause of persistent infections. 1999;284(5418):1318–22.

Jahangir MA, Imam SS, Muheem A, Chettupalli A, Al-Abbasi FA, Nadeem MS, et al. Nanocrystals: characterization overview, applications in drug delivery, and their toxicity concerns. J Pharm Innov. 2022;17(1):237–48.

Article  Google Scholar 

Venkataraman M, Nagarsenker M. Silver sulfadiazine nanosystems for burn therapy. AAPS PharmSciTech. 2013;14(1):254–64.

Article  CAS  PubMed  Google Scholar 

Gao L, Gan H, Meng Z, Gu R, Wu Z, Zhu X, et al. Evaluation of genipin-crosslinked chitosan hydrogels as a potential carrier for silver sulfadiazine nanocrystals. Colloid Surf B: Biointerfaces. 2016;148:343–53.

Article  CAS  PubMed  Google Scholar 

Liu X, Gan H, Hu C, Sun W, Zhu X, Meng Z et al. Silver sulfadiazine nanosuspension-loaded thermosensitive hydrogel as a topical antibacterial agent. Int J Nanomed. 2019:289–300.

Mastiholimath VS, Valerie CTW, Shrishailappa V, Mannur PMD, Gadad AP, Khanal P. Formulation and evaluation of solid lipid nanoparticle containing silver sulfadiazine for second and third degree burn wounds and its suitable analytical method development and validation. Indian J Pharm Educ Res. 2020;54:31–45.

Article  CAS  Google Scholar 

Malamatari M, Taylor KM, Malamataris S, Douroumis D, Kachrimanis K. Pharmaceutical nanocrystals: production by wet milling and applications. Drug Discovery Today. 2018;23(3):534–47.

Article  CAS  PubMed  Google Scholar 

Peltonen L, Hirvonen J. Pharmaceutical nanocrystals by nanomilling: critical process parameters, particle fracturing and stabilization methods. J Pharm Pharmacol. 2010;62(11):1569–79.

Article  CAS  PubMed  Google Scholar 

Nguyen TK, Peyrusson F, Siala W, Pham NH, Nguyen HA, Tulkens PM, et al. Activity of Moxifloxacin Against Biofilms formed by clinical isolates of Staphylococcus aureus Differing by their resistant or Persister Character to fluoroquinolones. Front Microbiol. 2021;12:785573.

Article  PubMed  PubMed Central  Google Scholar 

Tuomela A, Hirvonen J, Peltonen LJP. Stabilizing agents for drug nanocrystals: effect on bioavailability. 2016;8(2):16.

Sargam Y, Wang K, Tsyrenova A, Liu F, Jiang S. Effects of anionic and nonionic surfactants on the dispersion and stability of nanoSiO2 in aqueous and cement pore solutions. Cem Concr Res. 2021;144:106417.

Article  CAS  Google Scholar 

Attama AA, Momoh MA, Builders PF. Lipid nanoparticulate drug delivery systems: a revolution in dosage form design and development. Recent Adv Novel drug Carrier Syst. 2012;5:107–40.

Google Scholar 

Tran BN, Tran HT, Le GT, Tran HP, Le KN, Do HH et al. Solidifying Fenofibrate Nanocrystal Suspension: A Scalable Approach via Granulation Method. 2023;2023.

Tran BN, Nguyen HT, Kim JO, Yong CS, Nguyen, CNJAopr. Combination of a chemopreventive agent and paclitaxel in CD44-targeted hybrid nanoparticles for breast cancer treatment. 2017;40:1420–32.

Bult A, Plug CM. Silver sulfadiazine. Analytical profiles of Drug Substances. Volume 13. Elsevier; 1984. pp. 553–71.

Sheskey PJHB, Moss GP, Goldfarb DJ. Handbook of pharmaceutical excipients: Edition 9. Pharmaceutical; 2020.

Iwai I, Han H, Hollander Ld, Svensson S, Öfverstedt L-G, Anwar J, et al. The human skin barrier is Organized as stacked bilayers of fully extended ceramides with Cholesterol Molecules Associated with the Ceramide Sphingoid Moiety. J Invest Dermatology. 2012;132(9):2215–25.

Article  CAS  Google Scholar 

Dannert C, Stokke BT, Dias RS. Nanoparticle-hydrogel composites: from molecular interactions to macroscopic behavior. 2019;11(2):275.

Tran BN, Tran KL, Nguyen TT, Bui LT, Nguyen CN. A Novel Alginate Film based on Nanocoating Approach for enteric-release tablets. AAPS PharmSciTech. 2023;24(4):99.

Article  CAS  PubMed  Google Scholar 

Nguyen TK, Argudín MA, Deplano A, Nhung PH, Nguyen HA, Tulkens PM et al. Antibiotic resistance, biofilm formation, and intracellular survival as possible determinants of persistent or recurrent infections by staphylococcus aureus in a Vietnamese tertiary hospital: focus on bacterial response to moxifloxacin. 2020;26(6):537–44.

Siala W, Kucharíková S, Braem A, Vleugels J, Tulkens PM, Mingeot-Leclercq M-P, et al. The antifungal caspofungin increases fluoroquinolone activity against Staphylococcus aureus biofilms by inhibiting N-acetylglucosamine transferase. Nat Commun. 2016;7(1):13286.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cerca N, Pier GB, Vilanova M, Oliveira R, Azeredo, JJRim. Quantitative analysis of adhesion and biofilm formation on hydrophilic and hydrophobic surfaces of clinical isolates of Staphylococcus epidermidis. 2005;156(4):506–14.

Mizdal CR, Stefanello ST, da Costa Flores V, Agertt VA, Bonez PC, Rossi GG et al. The antibacterial and anti-biofilm activity of gold-complexed sulfonamides against methicillin-resistant Staphylococcus aureus. 2018;123:440–8.

Vaze N, Demokritou P. Using engineered water nanostructures (EWNS) for wound disinfection: case study of Acinetobacter baumannii inactivation on skin and the inhibition of biofilm formation. Nanomed Nanotechnol Biol Med. 2022;42:102537.

Article  CAS  Google Scholar 

Siqueira FS, Alves CFS, Machado AK, Siqueira JD, Santos Td, Mizdal CR et al. Molecular docking, quorum quenching effect, antibiofilm activity and safety profile of silver-complexed sulfonamide on Pseudomonas aeruginosa. 2021;37(5):555–71.

Comments (0)

No login
gif